[go: up one dir, main page]

FI810956L - Nya 3-(1-piperidinylalkyl)-4h-pyrido/1,2-a/pyrimidin-4-on-derivat - Google Patents

Nya 3-(1-piperidinylalkyl)-4h-pyrido/1,2-a/pyrimidin-4-on-derivat

Info

Publication number
FI810956L
FI810956L FI810956A FI810956A FI810956L FI 810956 L FI810956 L FI 810956L FI 810956 A FI810956 A FI 810956A FI 810956 A FI810956 A FI 810956A FI 810956 L FI810956 L FI 810956L
Authority
FI
Finland
Prior art keywords
piperidinylalkyl
nya
pyrido
pyrimidin
derivatives
Prior art date
Application number
FI810956A
Other languages
English (en)
Other versions
FI71737C (fi
FI71737B (fi
Inventor
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI810956L publication Critical patent/FI810956L/fi
Application granted granted Critical
Publication of FI71737B publication Critical patent/FI71737B/fi
Publication of FI71737C publication Critical patent/FI71737C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI810956A 1980-03-28 1981-03-27 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(piperidinylalkyl)-4h-pyrido/1,2-a/ pyrimidin-4-on-derivat. FI71737C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28
US13484580 1980-03-28
US06/191,632 US4342870A (en) 1980-03-28 1980-09-29 Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US19163280 1980-09-29

Publications (3)

Publication Number Publication Date
FI810956L true FI810956L (fi) 1981-09-29
FI71737B FI71737B (fi) 1986-10-31
FI71737C FI71737C (fi) 1987-02-09

Family

ID=26832744

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810956A FI71737C (fi) 1980-03-28 1981-03-27 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(piperidinylalkyl)-4h-pyrido/1,2-a/ pyrimidin-4-on-derivat.

Country Status (22)

Country Link
US (1) US4342870A (fi)
EP (1) EP0037265B1 (fi)
AU (1) AU537700B2 (fi)
BG (1) BG36199A3 (fi)
CA (1) CA1163994A (fi)
CS (1) CS256366B2 (fi)
DE (1) DE3168433D1 (fi)
DK (1) DK159390C (fi)
ES (1) ES8300763A1 (fi)
FI (1) FI71737C (fi)
GR (1) GR72488B (fi)
HU (1) HU187329B (fi)
IE (1) IE51319B1 (fi)
IL (1) IL62494A (fi)
MA (1) MA19107A1 (fi)
NO (1) NO156752C (fi)
NZ (1) NZ196522A (fi)
PH (1) PH16530A (fi)
PT (1) PT72740B (fi)
RO (1) RO82508A (fi)
SU (1) SU1068037A3 (fi)
YU (1) YU43010B (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443451A (en) 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4548938A (en) * 1981-07-15 1985-10-22 Janssen Pharmaceutica N.V. 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4581171A (en) * 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4888426A (en) * 1983-11-30 1989-12-19 Janssen Pharmaceutica N.V. 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine
US4695569A (en) * 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
SG47757A1 (en) * 1986-09-22 1998-04-17 Janssen Pharmaceutica Nv Serotonin antagonists for treating wounds
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
CA2000786C (en) * 1988-11-07 1999-01-26 Cornelus G. M. Janssen 3-piperidinyl-1,2-benzisoxazoles
WO1990006303A1 (en) * 1988-12-02 1990-06-14 Pfizer Inc. Arylpiperidine derivatives
JPH04504263A (ja) * 1989-03-23 1992-07-30 マリンクロッド・インコーポレイテッド 放射性沃素又は臭素標識ピペリジン化合物、並びに上記化合物の及び上記化合物を含む組成物の製法
DE4138756A1 (de) * 1991-11-26 1993-05-27 Troponwerke Gmbh & Co Kg Kombination mit neuroprotektiver wirkung
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
ES2163407T3 (es) * 1992-02-13 2002-02-01 Merrell Pharma Inc Derivados piperidinilos tiaciclicos.
DE69330283T2 (de) * 1992-07-13 2002-01-10 Janssen Pharmaceutica N.V., Beerse Neue 4-(3-benzofuranyl) piperidinyl und 4-(3-benzothienyl) piperidinyl-derivate und diese enthaltende pharmazeutische zusammenstellungen
PL314481A1 (en) 1993-11-19 1996-09-16 Janssen Pharmaceutica Nv Microencapsulated substituted 3-piperidinyl 1,2-benzoisoxazoles and 1,2-benzoisothiazoles
ES2085234B1 (es) * 1994-02-24 1997-01-16 Vita Invest Sa Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
TW421649B (en) * 1995-01-31 2001-02-11 Janssen Pharmaceutica Nv 4-(1H-indol-1yl)-1-piperidinyl derivatives
US5753664A (en) * 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
CN100390146C (zh) * 2002-11-13 2008-05-28 斯索恩有限公司 制备利培酮的方法和用于该方法的中间体
WO2004094415A1 (en) * 2003-04-22 2004-11-04 Synthon B.V. Risperidone monohydrochloride
DK3106166T3 (da) 2008-02-29 2021-01-11 Vm Therapeutics Llc Forbindelser til behandling af smertesyndrom og andre lidelser
SG11201404713PA (en) * 2012-02-10 2014-09-26 Ptc Therapeutics Inc Compounds for treating spinal muscular atrophy
MX352962B (es) 2012-03-01 2017-12-15 Ptc Therapeutics Inc Compuestos para tratar atrofia muscular espinal.
KR102109992B1 (ko) 2012-03-23 2020-05-13 피티씨 테라퓨틱스, 인크. 척수성 근위축증을 치료하기 위한 화합물
WO2014143915A1 (en) * 2013-03-15 2014-09-18 Vm Therapeutics Llc Novel crystalline forms
US10195202B2 (en) 2013-12-19 2019-02-05 Ptc Therapeutics, Inc. Methods for modulating the amount of RNA transcripts
WO2016196386A1 (en) 2015-05-30 2016-12-08 Ptc Therapeutics, Inc. Methods for modulating rna splicing
HUE055031T2 (hu) 2015-12-10 2021-10-28 Ptc Therapeutics Inc Módszerek Huntington-kór kezelésére
AU2017363369A1 (en) 2016-11-28 2019-05-30 Ptc Therapeutics, Inc Methods for modulating RNA splicing
JP7376471B2 (ja) 2017-06-05 2023-11-08 ピーティーシー セラピューティクス, インコーポレイテッド ハンチントン病を処置するための化合物
WO2018232039A1 (en) 2017-06-14 2018-12-20 Ptc Therapeutics, Inc. Methods for modifying rna splicing
WO2019005993A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
CN111182898B (zh) 2017-06-28 2024-04-16 Ptc医疗公司 用于治疗亨廷顿氏病的方法
CN112135815A (zh) 2018-03-27 2020-12-25 Ptc医疗公司 用于治疗亨廷顿氏病的化合物
ES2983003T3 (es) 2018-06-27 2024-10-21 Ptc Therapeutics Inc Compuestos heterocíclicos y heteroarílicos para el tratamiento de la enfermedad de Huntington
MX2020014315A (es) 2018-06-27 2021-05-27 Ptc Therapeutics Inc Compuestos de heteroarilo para tratar la enfermedad de huntington.
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412094A (en) * 1967-06-21 1968-11-19 Searle & Co 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
JPS5146497A (en) * 1974-10-19 1976-04-20 Masato Aiura Hobuban
JPS525795A (en) * 1975-06-28 1977-01-17 Sankyo Co Ltd Preparation of tetrahydro pyridopyrimidinone derivatives
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom

Also Published As

Publication number Publication date
NO156752C (no) 1987-11-18
EP0037265B1 (en) 1985-01-23
DK138281A (da) 1981-09-29
ES500814A0 (es) 1982-11-01
IE810706L (en) 1981-09-28
DK159390B (da) 1990-10-08
FI71737C (fi) 1987-02-09
YU43010B (en) 1989-02-28
MA19107A1 (fr) 1981-10-01
ES8300763A1 (es) 1982-11-01
PT72740B (en) 1982-11-16
HU187329B (en) 1985-12-28
BG36199A3 (en) 1984-09-14
RO82508A (ro) 1983-09-26
AU6842981A (en) 1981-10-01
NO156752B (no) 1987-08-10
IE51319B1 (en) 1986-12-10
NZ196522A (en) 1985-10-11
AU537700B2 (en) 1984-07-05
IL62494A0 (en) 1981-05-20
CA1163994A (en) 1984-03-20
RO82508B (ro) 1983-08-30
PH16530A (en) 1983-11-10
NO811058L (no) 1981-09-29
DE3168433D1 (de) 1985-03-07
CS256366B2 (en) 1988-04-15
GR72488B (fi) 1983-11-14
EP0037265A1 (en) 1981-10-07
US4342870A (en) 1982-08-03
DK159390C (da) 1991-03-04
SU1068037A3 (ru) 1984-01-15
FI71737B (fi) 1986-10-31
PT72740A (en) 1981-04-01
YU81081A (en) 1983-12-31
IL62494A (en) 1984-08-31

Similar Documents

Publication Publication Date Title
FI810956L (fi) Nya 3-(1-piperidinylalkyl)-4h-pyrido/1,2-a/pyrimidin-4-on-derivat
FI822266A0 (fi) Nya imidazo/1,2-a/pyridiner och pyraziner
FI812875L (fi) Nya n-arylbenzamidderivat
FI885021L (fi) Nya benzocykloheptenderivat.
FI885329A0 (fi) Nya fluorcytidinderivat.
FI822511A0 (fi) Nya bicykliska pyrimidin-5-on-derivat
FI834131A0 (fi) Nya derivat av tricykliska aminosyror, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning, samt nya bicykliska aminosyror saosom mellanskeden och foerfarande foderas framstaellning
FI884305L (fi) Nya amidinotricyklderivat.
FI885128A7 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara kinolinkarboxylsyraderivat.
ZA812085B (en) Novel 3-(1-piperidinylalkyl)4h-pyrido(1,2-a)pyrimidin-4one derivatives
FI782307A7 (fi) Foerfarande foer framstaellning av 5-substituerade 1,2-dihydro-3h-pyrrolo (1,2-a) pyrroli-1-karboxylsyror av motsvarande nya nitriler
FI860556L (fi) Nya 1,8-naftyridinderivat och foerfarande foer deras framstaellning.
FI822785L (fi) Nya imidazokinazolinderivat
FI864891A7 (fi) Foerfarande foer framstaellning av 6,7,8,9-tetrahydro-10-metylpyrido/1,2-a/indol-9-aminer och deras derivat.
FI833055A0 (fi) Framstaellningsfoerfarande foer nya imidazo/1,2-a/pyrimidiner
FI801464A7 (fi) Foerfarande foer framstaellning av substituerade pyrido/1,2-a/pyrimidiner
FI812303L (fi) Nya imidazokinazolinderivat
FI873297A7 (fi) Nya substituerade pyrido/2,3-b//1,4/ benzodiazepin-6-oner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel.
FI864003A7 (fi) Pyrido /1,2-a/ pyrimidinderivat, foerfaranden foer framstaellning daerav och dessa innehaollande farmaceutiska kompositioner foer behandling av allergiska sjukdomar.
DE3267918D1 (de) Pyrazolo(3,4-b)pyridine derivatives
FI822236L (fi) Nya imidazo/1,2-a/pyrimidiner, deras syraadditionssalter, dessa innehaollande laekemedel och foerfarande foer deras framstaellning
FI811577L (fi) Nya kinoxalin-1,4-dioxidderivat
FI820982L (fi) Nya 1,2-dihydropyrido/3,4-b/pyraziner och foerfarande och mellanprodukter foer framstaellning av desamma
FI813757L (fi) Nytt foerfarande foer framstaellning av imidazo/4,5-b/pyridiner och -pyrimidiner
FI845085A0 (fi) Nya imidazo/4,5-c/pyridin-oner, deras framstaellning och dessa foereningar innehaollande laekemedel.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: JANSSEN PHARMACEUTICA N.V.